Letizia Tiberia
Papers
1
Total Citations
23
H-Index
1
About
Dr. Letizia Tiberia is a leading urologic oncologist whose research focuses on upper tract urothelial carcinomas (UTUCs) and the optimization of perioperative care pathways. Her work critically examines the evolving landscape of neoadjuvant and adjuvant intravesical chemotherapy, particularly in patients undergoing radical nephroureterectomy. In her landmark 2021 study, Dr. Tiberia analyzed U.S. claims data to compare outcomes and healthcare costs between minimally invasive and open surgical approaches, revealing significant disparities in chemotherapy utilization and perioperative complications. This research, which has garnered 23 citations, provides actionable insights for balancing oncologic efficacy with economic sustainability in UTUC management. Dr. Tiberia’s contributions have been instrumental in shaping evidence-based protocols for high-risk patients, emphasizing the need for personalized treatment sequencing. Her work bridges surgical innovation and health policy, making her a pivotal voice in the transition toward value-based urologic oncology. For students and researchers, Dr. Tiberia exemplifies how rigorous data analysis can directly inform clinical decision-making and resource allocation in cancer care.
Research Focus
Key Achievements
Top Papers
- 1